In the present study, we observed that TGF-β treatment could induce EMT process in CRC cell line HT29, as evidenced by changes in cell morphologies and changed expression levels of Vimentin, Fibronectin, and others. This evidence concerns the gene TGFB1 and colorectal carcinoma.